We examined the antitumor activity of an intestinal bacterium-based, oral WT1 protein vaccine in a model of murine leukemia, and B. longum 420/2656 combination further accelerated antitumor activity that relies on WT1-specific CTLs in the tumor compared with B. longum 420. This evidence concerns the gene WT1 and leukemia.